These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35022563)

  • 1. The effects of visual-field loss from panretinal photocoagulation of proliferative diabetic retinopathy on performance in a driving simulator.
    Bro T; Andersson J
    Eye (Lond); 2023 Jan; 37(1):103-108. PubMed ID: 35022563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Visual Field Loss from Optic Disc Drusen on Performance in a Driving Simulator.
    Bro T; Andersson J
    Neuroophthalmology; 2022; 46(5):290-297. PubMed ID: 36337223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of visual field loss from glaucoma on performance in a driving simulator.
    Bro T; Andersson J
    Acta Ophthalmol; 2022 Mar; 100(2):218-224. PubMed ID: 33529454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
    Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
    JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR; Michelessi M; Virgili G
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
    Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
    Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Perception and the Relation to Actual Driving Abilities for Individuals With Visual Field Loss.
    Andersson J; Bro T; Lajunen T
    Front Hum Neurosci; 2022; 16():852794. PubMed ID: 35370585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy.
    Vernon SA; Bhagey J; Boraik M; El-Defrawy H
    Diabet Med; 2009 Jan; 26(1):97-9. PubMed ID: 19125769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
    Omari A; Niziol LM; Gardner TW
    Acta Ophthalmol; 2019 Nov; 97(7):e1013-e1018. PubMed ID: 30968579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
    Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
    Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
    Dogru M; Nakamura M; Inoue M; Yamamoto M
    Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy.
    Sun Y; Qi H
    Front Endocrinol (Lausanne); 2022; 13():1038757. PubMed ID: 36714571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
    Sivaprasad S; Prevost AT; Vasconcelos JC; Riddell A; Murphy C; Kelly J; Bainbridge J; Tudor-Edwards R; Hopkins D; Hykin P;
    Lancet; 2017 Jun; 389(10085):2193-2203. PubMed ID: 28494920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
    Zhang W; Zhao G; Fan W; Zhao T
    BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Visual Field Loss from Stroke on Performance in a Driving Simulator.
    Bro T; Andersson J
    Optom Vis Sci; 2022 Sep; 99(9):679-686. PubMed ID: 35914086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes.
    Bek T; Kjaergaard J
    Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.